Description
Therapy-orienting testing of BRCA1 and BRCA2 germline mutations in women with ovarian cancer
Article: Therapy-orienting testing of BRCA1 and BRCA2 germline mutations in women with ovarian cancer
€3.03
Related products
-
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€209.83 Add to cart -
Article: Highlights in urologic cancer
€3.03 Add to cart -
Article: Highlights in squamous cell carcinoma of the head and neck
€3.03 Add to cart
